Report of Content
Chapter 1 Methodology & Scope
1.1 Industry coverage
1.2 Market scope & definitions
1.3 Base estimates & working
1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact at global level
1.6 Data validation
1.7 Data sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Cardiac resynchronisation therapy devices industry 3600 synopsis, 2018 – 2032
2.2 Business trends
2.3 Regional trends
2.4 Product trends
2.5 Age trends
2.6 End-use
Chapter 3 Cardiac Resynchronisation Therapy Devices Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing incidence of cardiovascular disorders
3.2.1.2 Increasing geriatric population
3.2.1.3 Technological advancements
3.2.1.4 Favorable reimbursement scenario
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of CRT devices
3.2.2.2 Stringent regulatory scenario
3.3 Growth potential analysis
3.3.1 By product
3.3.2 By age
3.3.3 By end-use
3.4 COVID-19 impact analysis
3.5 Regulatory landscape
3.5.1 U.S.
3.5.2 Europe
3.6 Reimbursement scenario
3.7 Technology landscape
3.8 Future market trends
3.9 Porter’s analysis
3.10 Gap analysis
3.11 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Company market share analysis, 2022
4.4 Competitive positioning matrix
4.5 Vendor matrix analysis
4.6 Strategy dashboard, 2022
Chapter 5 Cardiac Resynchronisation Therapy Devices Market Size and Forecast, By Product (USD Million & Units)
5.1 Key technology trends
5.2 CRT-Pacemakers
5.2.1 MRI Compatible CRT-P Devices
5.2.2 Conventional CRT-P Devices
5.3 CRT-Defibrillators
5.3.1 MRI Compatible CRT-D Devices
5.3.2 Conventional CRT-D Devices
Chapter 6 Cardiac Resynchronisation Therapy Devices Market Size and Forecast, By Age (USD Million)
6.1 Key age trends
6.2 Below 44 years
6.3 45-64 years
6.4 65-84 years
6.5 Above 85 years
Chapter 7 Cardiac Resynchronisation Therapy Devices Market Size and Forecast, By End-use (USD Million)
7.1 Key end-use trends
7.2 Hospitals
7.3 Cardiac care centers
7.4 Ambulatory surgical centers
Chapter 8 Cardiac Resynchronisation Therapy Devices Market Size and Forecast, By Region (USD Million)
8.1 Key regional trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 South Korea
8.4.5 Australia
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Rest of Latin America
8.6 Middle East & Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Rest of MEA
Chapter 9 Company Profiles
9.1 Medtronic PLC
9.2 Abbott Laboratories
9.3 Biotronik
9.4 Boston Scientific Corporation
9.5 Microport Scientific Corporation
9.6 Medico S.p.A
9.7 LivaNova PLC
